12-ICML Sponsors
The 12-ICML Organizing Committee wishes to thank the following sponsors for their unrestricted financial support to the conference organization:
| Affymetrix UK Ltd. | www.affymetrix.com |  |
| Baxter | www.baxter.com |  |
| Bristol Myers Squibb SA | www.bms.ch |  |
| Celgene Corporation | www.celgene.com |  |
| Cytocell Ltd | www.cytocell.com |  |
| F. Hoffmann-La Roche Limited | www.roche.com |  |
| Gilead Sciences, Inc. |  |
|
| GlaxoSmithKline Oncology | www.gskoncology.com |  |
| Helsinn Healthcare SA | www.helsinn.com |  |
| Lilly Oncology | www.LillyOncology.com |  |
| Lipomed AG |  |
|
| Millennium: The Takeda Oncology Company | www.takeda.com |  |
| Mundipharma International Ltd | www.mundipharma.com |  |
| OrPha Swiss | www.orpha.ch |  |
| Pfizer Oncology |  |
|
| prIME Oncology | www.primeoncology.org |  |
| Spectrum Pharmaceuticals, Inc. | www.sppirx.com |  |
| Terumo BCT | www.terumobct.com |  |
| Varian Medical Systems | www.varian.com |  |
12-ICML Contributors
The 12-ICML Organizing Committee wishes to thank the following contributors for their collaboration to the conference:
| American Society of Clinical Oncology (ASCO) | www.asco.org |  |
| Banca dello Stato del Cantone Ticino |  |
|
| BSI SA |  |
|
| City of Lugano | www.lugano.ch |  |
| Comunità Tariffale Ticino e Moesano | www.arcobaleno.ch |  |
| Electronic Studio SA | www.electronicstudio.ch |  |
| European School of Oncology (ESO) | www.eso.net |  |
| European School of Oncology Foundation (ESOF) |  |
|
| European Society for Medical Oncology (ESMO) | www.esmo.org |  |
| GSI Suisse | www.gsisuisse.ch |  |
| Hotel Splendide Royal | www.splendide.ch |  |
| International Lymphoma Radiation Oncology Group (ILROG) | www.ilrog.org |  |
| Swiss Academy of Medical Sciences (SAMS) | www.samw.ch |  |
| Swiss Cancer League | www.swisscancer.ch |  |
| Swiss International Air Lines Ltd. |  |
| The conference organizers wish to thank the following colleagues for their professional help: ORGANIZING COMMITTEE: J.O. Armitage, Omaha, NE (USA) F. Bertoni, Bellinzona (Switzerland) M.F. Fey, Bern (Switzerland) R. Gascoyne, Vancouver (Canada) M.K. Gospodarowicz, Toronto (Canada) P.W.M. Johnson, Southampton (UK) T. A. Lister, London (UK) E. Zucca, Bellinzona (Switzerland) ADVISORY BOARD: E. Campo, Barcellona (Spain) B.D. Cheson, Washington, D.C. (USA) J.M. Connors, Vancouver (Canada) F.E. Cotter, London (UK) R. Dalla-Favera, New York, NY (USA) M. Dreyling, Munich (Germany) A. Engert, Cologne (Germany) J.W. Friedberg, Rochester, NY (USA) G. Gaidano, Novara (Italy) P. Gaulard, Créteil (France) M. Hallek, Cologne (Germany) N.L. Harris, Boston, MA (USA) E.S. Jaffe, Bethesda, MD (USA) J.P. Leonard, New York, NY (USA) A. Lopez-Guillermo, Barcelona (Spain) M.A. Piris, Madrid (Spain) S.A. Pileri, Bologna (Italy) S.V. Rajkumar, Rochester, MN (USA) A. Reiter, Giessen (Germany) F. Sallusto, Bellinzona (Switzerland) M. Seto, Nagoya (Japan) J.F. Seymour, Melbourne (Australia) M.A. Shipp, Boston, MA (USA) L. Specht, Copenhagen (Denmark) L.M. Staudt, Bethesda, MD (USA) C. Thieblemont, Paris (France) K. Tobinai, Tokyo (Japan) U. Vitolo, Turin (Italy) D.D. Weisenburger, Omaha, NE (USA) A. Younes, Houston, TX (USA) 12-ICML REVIEWERS’ LIST J.O. Armitage, Omaha, NE (USA) T. Batchelor, Boston, MA (USA) F. Bertoni, Bellinzona (Switzerland) E. Campo, Barcelona (Spain) F. Cavalli, Bellinzona (Switzerland) B.D. Cheson, Washington, D.C. (USA) B. Coiffier, Pierre Bénite (France) J.M. Connors, Vancouver, BC (Canada) F.E. Cotter, London (UK) R. Dalla-Favera, New York, NY (USA) A. Davies, Southampton (UK) S. De Sanjose Llongueras, L’Hospitalet-Barcelona (Spain) R. Dolcetti, Aviano (Italy) P. Dreger, Heidelberg (Germany) M. Dreyling, Munich (Germany) R. Dummer, Zürich (Switzerland) A. Engert, Cologne (Germany) M.R. Federico, Modena (Italy) A.J. Ferreri, Milan (Italy) M.F. Fey, Bern (Switzerland) J.W. Friedberg, Rochester, NY (USA) G. Gaidano, Novara (Italy) R.D. Gascoyne, Vancouver, BC (Canada) P. Gaulard, Créteil (France) M. Ghielmini, Bellinzona (Switzerland) C. Gisselbrecht, Paris (France) M.K. Gospodarowicz, Toronto (Canada) T.G. Gross, Columbus, OH (USA) A. Hagenbeek, Amsterdam (Netherlands) M. Hallek, Cologne (Germany) N.L. Harris, Boston, MA (USA) G. Illerhaus, Stuttgart (Germany) T. Illidge, Manchester (UK) E.S. Jaffe, Bethesda, MD (USA) P.W. Johnson, Southampton (UK) B. S. Kahl, Madison, WI (USA) I. Khouri, Houston, TX (USA) M. Ladetto, Turin (Italy) G. Lenz, Berlin (Germany) J.P. Leonard, New York, NY (USA) E. Lerch, Bellinzona (Switzerland) R. Levy, Stanford, CA (USA) A.T. Lister, London (UK) A. López Guillermo, Barcelona (Spain) M. Meignan, Créteil (France) A. Moccia, Bellinzona (Switzerland) S. Montoto, London (UK) E. Montserrat Costa, Barcelona (Spain) P. Moreau, Nantes (France) G. Nowakowski, Rochester, MN (USA) C. Patte, Villejuif (France) M. Pfreundschuh, Homburg (Germany) S.A. Pileri, Bologna (Italy) M.A. Piris, Santander (Spain) M. Ponzoni, Milan (Italy) B. Pro, Philadelphia, PA (USA) M. Raderer, Vienna (Austria) J. Radford, Manchester (UK) S. V. Rajkumar, Rochester, MN (USA) A. Reiter, Giessen (Germany) A. Rosenwald, Würzburg (Germany) D. Rossi, Novara (Italy) G. Salles, Pierre Bénite (France) F. Sallusto, Bellinzona (Switzerland) M. Seto, Nagoya (Japan) J.F. Seymour, East Melbourne (Australia) M.A. Shipp, Boston, MA (USA) L. Specht, Copenhagen (Denmark) M. Spina, Aviano (Italy) A. Stathis, Bellinzona (Switzerland) L.M. Staudt, Bethesda, MD (USA) S. Stroobants, Antwerpen (Belgium) C. Thieblemont, Paris (France) K. Tobinai, Tokyo (Japan) U. Vitolo, Turin (Italy) J.M. Vose, Omaha, NE (USA) D.D. Weisenburger, Duarte, CA (USA) S. Weitzman, Toronto, Ontario (Canada) W. Wilson, Bethesda, MD (USA) A. Younes, New York, NY (USA) P.L. Zinzani, Bologna (Italy) E. Zucca, Bellinzona (Switzerland) |
